@article{173c075b805d4cb2ae69005a9159d058,
title = "Brentuximab Vedotin (SGN-35) in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma: A Phase 2 Study Update",
author = "Advani, \{Ranjana H.\} and Shustov, \{Andrei R.\} and Pauline Brice and Bartlett, \{Nancy L.\} and Rosenblatt, \{Joseph D.\} and Tim Illidge and Jeffrey Matous and Radhakrishnan Ramchandren and Fanale, \{Michelle A.\} and Connors, \{Joseph M.\} and Yin Yang and Kennedy, \{Dana A.\} and Barbara Pro",
note = "624. Lymphoma - Therapy with Biologic Agents, excluding Pre-Clinical Models: Mantle Cell and T Cell Lymphoma - Targeted Antibody and Small Molecule Approaches | Ranjana H. Advani, Andrei R. Shustov, Pauline Brice, Nancy L. Bartlett, Joseph D. Rosenblatt, Tim Illidge, Jeffrey Matous, Radhakrishnan Ramchandren, Michelle A. Fanale, Joseph M.",
year = "2011",
month = nov,
day = "18",
doi = "10.1182/BLOOD.V118.21.443.443",
language = "American English",
volume = "118",
journal = "Blood",
publisher = "American Society of Hematology",
number = "21",
}